Sandbox endocarditis: Difference between revisions
Jump to navigation
Jump to search
Line 54: | Line 54: | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Rifampin]] 20 mg per kg per 24 h PO/IV in 3 equally divided doses''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Rifampin]] 20 mg per kg per 24 h PO/IV in 3 equally divided doses''''' | ||
|- | |- | ||
| | ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Prosthetic valve (late—greater than 1 y) (same regimens as for native valve endocarditis with addition of [[rifampin]])}}'' | ||
{| | |||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin sulbactam|Ampicillin-Sulbactam]] 3 g q6h IV x 4–6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Gentamicin|Gentamicin sulfate]] 1 mg per kg q8h IV/IM x 4–6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Rifampin]] 300 mg q8h PO/IV x 6 weeks''''' | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin sulbactam|Ampicillin-Sulbactam]]''''' | |||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''OR'' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''OR'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] 15 mg per kg q12h IV x 4–6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Gentamicin|Gentamicin sulfate]] 1 mg per kg q8h IV/IM x 4–6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Ciprofloxacin]] 500 mg q12h PO or 400 mg q12h IV x 4–6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Rifampin]] 300 mg q8h PO/IV x 6 weeks''''' | ||
|- | |- | ||
|} | |} |
Revision as of 14:25, 15 January 2014
Empirical Antibiotic Therapy
- Antibiotic therapy for subacute disease, and in those who have received antibiotics recently can be delayed waiting the results of blood cultures, as this delay allows an additional blood cultures without the confounding effect of empiric treatment, which is very important in determining the causing pathogens.[1]
- On the other hand, the rapid progression of acute cases necessitate the start of empirical treatment antibiotic therapy once the blood cultures have been collected.
- Empirical therapy is needed for all likely pathogens, certain antibiotic agents, including aminoglycosides, is preferably avoided for its toxic effects.
- Clinical course of infection beside the epidemiological features should be considered upon selecting empirical treatment regimen.
- Consultation with an infectious disease specialist for the selection of one of the antibiotic regimens is recommended(See therapy for culture-negative endocarditis). [2]
|